Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
The strength of my opinion here exceeds the strength of my evidence.
Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
The strength of my opinion here exceeds the strength of my evidence.
Subcutaneous absorption kinetics and site: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.
Taking post #13 at face value and following it one step further.
One caution on subcutaneous absorption kinetics and site: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
This follows post #17 rather than contradicting it.
Reading this subcutaneous absorption kinetics and site thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
A definition problem is doing most of the work in this subcutaneous absorption kinetics and site discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.
Read the full topic (20 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
[2026 update] Clearance pathways and what renal impairment changes
On the subject in the title: Clearance pathways and what renal impairment changes Working notes rather than a conclusion. What changes if the standard account of Clearance pathways is wrong? I ask because I…
|
+63 | 69 | 50k | 13mo |
|
Follow-up: Subcutaneous absorption kinetics and site differences
Subcutaneous absorption kinetics and site differences — setting out what I have, and where I think it stops being reliable. A follow-up question about Subcutaneous absorption kinetics and site that I did not…
|
4 | 9.9k | 10mo | |
|
Peak-to-trough ratio at steady state for a weekly agent
On the subject in the title: Peak-to-trough ratio at steady state for a weekly agent Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the…
|
+58 | 64 | 9.7k | 2mo |
|
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of clearance pathways is wrong? I…
|
+11 | 15 | 43k | 2mo |
|
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I think the…
|
+104 | 110 | 16k | 2d |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Reading U-100 graduations, with a conversion table
Posting this under the heading it deserves: Reading U-100 graduations, with a conversion table Everything below is what sits behind that. A question about reading U-100 graduations that I think has a definite…
|
+35 | 41 | 2k | 1d |
|
Reaching a dose and staying there for a year: a longitudinal note — does this still hold?
Asking directly, because I could not find a straight answer: Reaching a dose and staying there for a year: a longitudinal note — does this still hold? I have read the maintained page on this and I still have…
|
+35 | 39 | 547 | 11mo |
|
Why most self-reports here are not experiments, and that is fine
Why most self-reports here are not experiments, and that is fine — that is the question, and I have not found it answered plainly anywhere I have looked. A question about what a single-person experiment can…
|
2 | 46k | 11mo | |
|
Follow-up: A partial dose because the pen emptied mid-injection
Posting this under the heading it deserves: A partial dose because the pen emptied mid-injection Everything below is what sits behind that. A follow-up question about partial dose because the pen that I did…
|
+10 | 14 | 10k | 23mo |
|
How to disagree with an answer you were given, well
How to disagree with an answer you were given, well — that is the question, and I have not found it answered plainly anywhere I have looked. Question in the title and the context underneath, in the order the…
|
+9 | 13 | 1.6k | 1mo |